)
Acutus Medical (AFIB) investor relations material
Acutus Medical Q4 2024 earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Executive summary
2024 revenue from continuing operations reached $20.2 million, up 181% year-over-year from $7.2 million.
Operating loss for continuing operations narrowed to $0.1 million from $11.7 million last year.
Net loss from continuing operations was $4.6 million, with net loss per share at $0.16, compared to $11.9 million and $0.40 per share last year.
Loss on discontinued operations was $5.0 million, a significant improvement from $69.7 million last year.
Company realigned focus to left-heart access products and exited electrophysiology mapping and ablation businesses.
Financial highlights
Gross margin for continuing operations improved to 5% from negative 44% year-over-year, driven by higher production volumes and reduced overhead.
Operating expenses for continuing operations dropped to $1.1 million from $8.6 million, reflecting reduced discretionary spend.
Cash, cash equivalents, marketable securities, and restricted cash totaled $14.0 million as of December 31, 2024.
Gain on sale of business was $10.8 million, up 19% year-over-year.
Outlook and guidance
No further financial guidance will be provided due to the business realignment and exit from certain business lines.
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
)
)